AI Verdict
HRMY has stronger fundamentals based on our AI analysis.
HROW vs HRMY Fundamental Comparison
| Metric | HROW | HRMY |
|---|---|---|
| Revenue | $272.3M | $868.5M |
| Net Income | $-5.1M | $158.7M |
| Net Margin | -1.9% | 18.3% |
| ROE | -9.8% | 18.2% |
| ROA | -1.3% | 12.5% |
| Current Ratio | 2.20x | 3.60x |
| Debt/Equity | 4.77x | 0.19x |
| EPS | $-0.14 | $2.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HROW vs HRMY: Frequently Asked Questions
Is HROW or HRMY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRMY has stronger fundamentals. HROW is rated HOLD (68% confidence) while HRMY is rated BUY (78% confidence). This is not investment advice.
How does HROW compare to HRMY fundamentally?
HARROW, INC. has ROE of -9.8% vs Harmony Biosciences Holdings, Inc.'s 18.2%. Net margins are -1.9% vs 18.3% respectively.
Which stock pays higher dividends, HROW or HRMY?
HROW has a dividend yield of N/A or no dividend while HRMY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HROW or HRMY for long term?
For long-term investing, consider that HROW has HOLD rating with 68% confidence, while HRMY has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HROW vs HRMY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HROW vs HRMY, the AI consensus favors HRMY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.